---
title: "West Pharmaceutical Q4 Adjusted Earnings Decline, Revenue Rises; Provides 2025 Guidance"
date: "2025-02-13 19:20:39"
summary: "West Pharmaceutical Services reported Q4 adjusted earnings Thursday of $1.82 per diluted share, down from $1.83 a year earlier. Analysts polled by FactSet expected $1.72. Revenue for the quarter ended Dec. 31 was $748.8 million compared with $732 million a year earlier. Analysts surveyed by FactSet expected $740 million. The..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

West Pharmaceutical Services reported Q4 adjusted earnings Thursday of $1.82 per diluted share, down from $1.83 a year earlier.

Analysts polled by FactSet expected $1.72.

Revenue for the quarter ended Dec. 31 was $748.8 million compared with $732 million a year earlier.

Analysts surveyed by FactSet expected $740 million.

The company said it expects 2025 adjusted-diluted EPS to range from $6 to $6.20. Analysts surveyed by FactSet expect $7.45. The company expects revenue for the year to be $2.88 billion to $2.91 billion. Analysts polled by FactSet expect $3.04 billion.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250213:A3316351:0/)
